Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Yes. To your point though, it is still quite scientifically difficult. It's not like software here. We're like, yeah, yeah, yeah. I write some code and it's like, no, no, you still got to find a molecule that does what you say it does. Yep. So this leads to a whole bunch of lawsuits. It actually ends up going to the Danish Supreme Court where Hagedorn represents Nordisk himself.
0
💬
0
Comments
Log in to comment.
There are no comments yet.